We are live on
!
Find out more
Loomis, Sayles & Company Portfolio holdings
AUM
$74.3B
1-Year Est. Return
24.01%
This Fund
S&P 500
This Quarter
Est. Return
+7.28%
1 Year Est. Return
+24.01%
3 Year Est. Return
+109.67%
5 Year Est. Return
+145.58%
10 Year Est. Return
+623.08%
AUM
$42.5B
AUM Growth
+$2.36B
(+5.9%)
Cap. Flow
-$129M
Cap. Flow
% of AUM
-0.3%
Top 10 Holdings %
Top 10 Hldgs %
33.33%
Holding
1,050
New
87
Increased
310
Reduced
398
Closed
100
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$78.2M |
| 2 |
Amazon
AMZN
|
+$74.6M |
| 3 |
Cisco
CSCO
|
+$69.3M |
| 4 |
Monster Beverage
MNST
|
+$68.9M |
| 5 |
Oracle
ORCL
|
+$67.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Intel
INTC
|
+$449M |
| 2 |
AGN.PRA
Allergan plc
AGN.PRA
|
+$175M |
| 3 |
AutoZone
AZO
|
+$87M |
| 4 |
Varex Imaging
VREX
|
+$49M |
| 5 |
CVS Health
CVS
|
+$44M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.75% |
| 2 | Consumer Discretionary | 15.19% |
| 3 | Healthcare | 12.92% |
| 4 | Financials | 12.83% |
| 5 | Communication Services | 10.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
SLB Ltd
SLB
$73.6B
| $530M | 1.25% |
8,049,267
+428,523
| +6% | +$30.7M |
|
27
Factset
FDS
$9.36B
| $502M | 1.18% |
3,022,993
+96,434
| +3% | +$15.8M |
|
28
Yum! Brands
YUM
$42.2B
| $499M | 1.17% |
6,764,045
+384,357
| +6% | +$26.7M |
|
29
Yum China
YUMC
$16.5B
| $465M | 1.09% |
11,794,578
+909,192
| +8% | +$32.8M |
|
30
American Express
AXP
$227B
| $446M | 1.05% |
5,298,843
+206,101
| +4% | +$16.3M |
|
31
Merck
MRK
$322B
| $376M | 0.88% |
6,142,174
+82,711
| +1% | +$5.03M |
|
32
Ford
F
$58.5B
| $350M | 0.82% |
31,304,878
-15,000
| -0% | -$167K |
|
33
Automatic Data Processing
ADP
$106B
| $270M | 0.64% |
2,638,429
+182,756
| +7% | +$18.5M |
|
34
Comcast
CMCSA
$85B
| $168M | 0.39% |
4,307,522
-502,377
| -10% | -$19.8M |
|
35
UnitedHealth
UNH
$376B
| $163M | 0.38% |
877,790
-51,933
| -6% | -$9.11M |
|
36
Wells Fargo
WFC
$261B
| $147M | 0.35% |
2,650,588
-464,010
| -15% | -$24.9M |
|
37
JPMorgan Chase
JPM
$935B
| $135M | 0.32% |
1,479,977
-174,100
| -11% | -$15M |
|
38
Analog Devices
ADI
$179B
| $126M | 0.3% |
1,613,804
+103,546
| +7% | +$8.23M |
|
39
Bank of America
BAC
$435B
| $113M | 0.27% |
4,669,315
-310,427
| -6% | -$7.24M |
|
40
Roper Technologies
ROP
$38.8B
| $109M | 0.26% |
472,502
+37,719
| +9% | +$8.35M |
|
41
Apple
AAPL
$4.54T
| $108M | 0.26% |
3,012,096
-569,392
| -16% | -$21.1M |
|
42
Pfizer
PFE
$143B
| $100M | 0.24% |
3,136,977
-161,637
| -5% | -$5.1M |
|
43
Sherwin-Williams
SHW
$82.7B
| $99.3M | 0.23% |
848,580
-6,531
| -0.8% | -$730K |
|
44
Newell Brands
NWL
$2.38B
| $98.3M | 0.23% |
1,833,397
-469,998
| -20% | -$23.8M |
|
45
Northrop Grumman
NOC
$77.1B
| $94M | 0.22% |
366,208
-17,653
| -5% | -$4.42M |
|
46
Corning
GLW
$119B
| $89M | 0.21% |
2,961,128
| – | – |
|
47
Marriott International
MAR
$98.3B
| $88.2M | 0.21% |
879,391
-46,466
| -5% | -$4.65M |
|
48
Medtronic
MDT
$109B
| $87.8M | 0.21% |
989,256
-103,281
| -9% | -$8.71M |
|
49
PNC Financial Services
PNC
$99.7B
| $86.1M | 0.2% |
689,401
-74,291
| -10% | -$8.96M |
|
50
PepsiCo
PEP
$190B
| $85.8M | 0.2% |
743,060
+62,699
| +9% | +$7.19M |
|
Similar funds
CBU
BC
Loomis, Sayles & Company's Q2 2017 Portfolio in Review
As of Q2 2017, Loomis, Sayles & Company held 1,050 positions worth $42.5B, up 5.9% from $40.1B the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Loomis, Sayles & Company's Q2 2017 filing shows 87 new, 310 increased, 398 reduced and 100 closed positions. Its largest new stake was Danaher: 762,466 shares worth $57M. The largest sale was Intel, an estimated $449M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 19% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- Loomis, Sayles & Company's largest Q2 2017 buy was Danaher: 762,466 shares worth $57M.
- Loomis, Sayles & Company added most to Visa in Q2 2017, an estimated $78.2M increase.
- Loomis, Sayles & Company's biggest Q2 2017 reduction was Allergan plc, cutting an estimated $175M.
- Loomis, Sayles & Company fully exited Intel in Q2 2017, selling an estimated $449M.
- Loomis, Sayles & Company's ten largest holdings make up 33% of its $42.5B portfolio in Q2 2017.
- Loomis, Sayles & Company opened 87 new positions and closed 100 in Q2 2017.
- Loomis, Sayles & Company's portfolio value rose 5.9% quarter-over-quarter to $42.5B.
Based on Loomis, Sayles & Company's 13F filing for Q2 2017, filed 14 Aug 2017.